FinTrust Capital Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.73K | Sell |
473
-77
| -14% | -$1.1K | ﹤0.01% | 1016 |
|
|
2024
Q2 | $7.12K | Buy |
550
+147
| +36% | +$1.9K | ﹤0.01% | 944 |
|
|
2024
Q1 | $5.6K | Sell |
403
-118
| -23% | -$1.64K | ﹤0.01% | 946 |
|
|
2023
Q4 | $7.44K | Hold |
521
| – | – | ﹤0.01% | 859 |
|
|
2023
Q3 | $8.06K | Sell |
521
-114
| -18% | -$1.76K | ﹤0.01% | 807 |
|
|
2023
Q2 | $9.91K | Hold |
635
| – | – | ﹤0.01% | 765 |
|
|
2023
Q1 | $9.91K | Hold |
635
| – | – | ﹤0.01% | 764 |
|
|
2022
Q4 | $9.91K | Sell |
635
-15
| -2% | -$234 | ﹤0.01% | 764 |
|
|
2022
Q3 | $8K | Hold |
650
| – | – | ﹤0.01% | 938 |
|
|
2022
Q2 | $9K | Hold |
650
| – | – | ﹤0.01% | 919 |
|
|
2022
Q1 | $10K | Sell |
650
-177
| -21% | -$2.72K | ﹤0.01% | 950 |
|
|
2021
Q4 | $11K | Sell |
827
-120
| -13% | -$1.6K | ﹤0.01% | 898 |
|
|
2021
Q3 | $16K | Sell |
947
-11
| -1% | -$186 | ﹤0.01% | 789 |
|
|
2021
Q2 | $16K | Sell |
958
-89
| -9% | -$1.49K | ﹤0.01% | 799 |
|
|
2021
Q1 | $19K | Hold |
1,047
| – | – | 0.01% | 727 |
|
|
2020
Q4 | $19K | Buy |
1,047
+193
| +23% | +$3.5K | 0.01% | 688 |
|
|
2020
Q3 | $15 | Hold |
854
| – | – | ﹤0.01% | 708 |
|
|
2020
Q2 | $15K | Sell |
854
-99
| -10% | -$1.74K | 0.01% | 672 |
|
|
2020
Q1 | $14K | Sell |
953
-234
| -20% | -$3.44K | 0.01% | 697 |
|
|
2019
Q4 | $23K | Buy |
1,187
+61
| +5% | +$1.18K | 0.01% | 605 |
|
|
2019
Q3 | $19K | Buy |
1,126
+68
| +6% | +$1.15K | 0.01% | 644 |
|
|
2019
Q2 | $19K | Sell |
1,058
-157
| -13% | -$2.82K | 0.01% | 616 |
|
|
2019
Q1 | $25K | Buy |
1,215
+468
| +63% | +$9.63K | 0.01% | 542 |
|
|
2018
Q4 | $13K | Buy |
+747
| New | +$13K | 0.01% | 697 |
|